An 18-month-old in London, England, is one of the youngest children to receive gene therapy to treat hearing loss caused by a mutation in the OTOF gene. This gene produces a protein called Otoferlin that allows for communication between cells of the cochlea and the brain.
The recipient received an infusion of a functional copy of the OTOF in her ear. The procedure was completed in just 16 minutes. Reportedly, it only took a few weeks for the child to begin to hear and respond to sounds without the help of her cochlear implant.
References
Afzali K. (2024) Toddler born deaf can hear after gene therapy trial breakthrough her parents call “mind-blowing.”CBS News(accessed May 13, 2024).
Recent Posts
Your Professional Growth Starts Here
Ready to level up your career? You told us professional and leadership growth matters—especially for those newer to the field and eager to build their…
Termination of Federal EHDI Grants
Earlier this week, the Academy learned that seven federal cooperative agreements funded by the U.S. Health Resources and Services Administration (HRSA) are being terminated. Despite…
Discover What’s New (and Worth the Trip) at AAA 2026
We’re gearing up for an unforgettable convention, and we’re excited to share what’s new in San Antonio! This year’s convention brings fresh programming, expanded learning…


